Michael York

Insider Reports History

Entity
Individual
Location
C/O Phasebio Pharmaceuticals, Inc., 1 Great Valley Pkwy., Suite 30, Malvern, PA
Signature
/s/ Michael York
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael York:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Metacrine, Inc. Chief Business Officer Common Stock 103K $48.6K $0.47 Jan 26, 2023 Direct
PhaseBio Pharmaceuticals Inc VP, Corporate Development Common Stock 7.06K May 20, 2021 Direct

Insider Reports Filed by Michael York

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MTCR Metacrine, Inc. Jan 26, 2023 1 -$44.3K 4 Jan 27, 2023 Chief Business Officer
MTCR Metacrine, Inc. Feb 27, 2022 2 $0 4 Mar 1, 2022 Chief Business Officer
MTCR Metacrine, Inc. Feb 18, 2022 0 $0 3 Feb 24, 2022 Chief Business Officer
PHASQ PhaseBio Pharmaceuticals Inc May 20, 2021 1 $8.11K 4 May 24, 2021 VP, Corporate Development